Asston Pharmaceuticals Share Price
108.50-0.45 (-0.41%)
+7.96% past 1 Year
Corporate filings & documents
Announcements
7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.
1 week ago7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.
1 week agoNotice of 7th Annual General Meeting scheduled to be held on 29th September 2026 at 12:30 P.M.
1 week agoNotice of 7th Annual General Meeting scheduled to be held on 29th September 2026 at 12:30 P.M.
1 week agoAllotment of 24 10 431 equity shares via Preferential Allotment
2 weeks agoAllotment of 24 10 431 equity shares via Preferential Allotment
2 weeks agoAllotment of 24 10 431 equity shares via Preferential Allotment
2 weeks agoAllotment of 24 10 431 equity shares via Preferential Allotment
2 weeks agoFixing Record date/Cut-off date to determine eligible shareholders for the E-voting facility for the 7th Annual General Meeting of the Company
2 weeks agoFixing Record date/Cut-off date to determine eligible shareholders for the E-voting facility for the 7th Annual General Meeting of the Company
2 weeks agoFixing 29th September 2026 as the date for convening the 7th Annual General Meeting of the Company.
2 weeks agoFixing 29th September 2026 as the date for convening the 7th Annual General Meeting of the Company.
2 weeks agoMeeting Update
2 weeks agoMeeting Update
2 weeks agoChange in Management
2 weeks agoChange in Management
2 weeks agoAppointment of Statutory Auditor
2 weeks agoAppointment of Statutory Auditor
2 weeks agoOutcome of the Board Meeting.
2 weeks agoOutcome of the Board Meeting.
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali
2 weeks agoAsston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. Appointment of M/s Panchal S K & Associates (Peer Review Certificate No.: 018089 and Firm Registration No.: 145989W) as Statutory Auditor of the Company;2. The directors retiring by rotation;3. The date and draft notice of the 7th Annual General Meeting of the Company;4. Other incidental matters
3 weeks agoAsston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. Appointment of M/s Panchal S K & Associates (Peer Review Certificate No.: 018089 and Firm Registration No.: 145989W) as Statutory Auditor of the Company;2. The directors retiring by rotation;3. The date and draft notice of the 7th Annual General Meeting of the Company;4. Other incidental matters
3 weeks agoVoting Result and Scrutinizer report for EGM held on 31st July 2026 through VC-OAVM
1 month agoVoting Result and Scrutinizer report for EGM held on 31st July 2026 through VC-OAVM
1 month agoOutcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27 scheduled to be held on 31st July 2026 at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.
1 month agoOutcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27 scheduled to be held on 31st July 2026 at 12:30 P.M. through Video Conferencing and Other Audio-Visual Means.
1 month agoCertificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018.
2 months agoCertificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018.
2 months agoNewspaper Publication
2 months agoNewspaper Publication
2 months agoNotice of Second Extraordinary General Meeting for F.Y. 2026-27
2 months agoNotice of Second Extraordinary General Meeting for F.Y. 2026-27
2 months agoMeeting Update
2 months agoMeeting Update
2 months agoAnnouncement regarding Extraordinary General Meeting of the Company.
2 months agoAnnouncement regarding Extraordinary General Meeting of the Company.
2 months agoUpdate on Board Meeting Scheduled to be held on 02nd July 2026.
2 months agoUpdate on Board Meeting Scheduled to be held on 02nd July 2026.
2 months agoDisclosure under regulation 30 (LODR)- Preferential Issue
2 months agoDisclosure under regulation 30 (LODR)- Preferential Issue
2 months agoOutcome of the Board Meeting Scheduled to be held on 02nd July 2026.
2 months agoOutcome of the Board Meeting Scheduled to be held on 02nd July 2026.
2 months agoAnnual reports
Concalls & investor presentations
No presentations found